A research team of Israel has discovered a molecular mechanism of vaccination for Type 1 diabetes. Professor Irun Cohen of the Weizmann Institute of Science says that the vaccination is in the sophisticated stage of the study. The further research will intensify the efficacy of the vaccine. The vaccine apprehends the evolution of Type 1 diabetes in laboratory animals. The researchers found HSP60, a protein substance and a tiny fragment of it, p277, a peptide. It may put down the autoimmune response, which causes diabetes. The Journal of Clinical Investigation has published the report describing about the exact immune cells that p277 works on. The report illustrates the method of its function.
Diabetes vaccine is possible now
Posted April 25th 2012 at 10:48 am by admin
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or create a trackback from your own site.
There are no comments yet, be the first to say something
